Sterling Investment Advisors, Ltd. Gsk PLC Transaction History

Sterling Investment Advisors, Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	BUY	$40.23 - $47.74 $185,500 - $220,129	4,611 Added 1844.4%	4,861 $212,000
Q2 2021 Jul 29, 2021	SELL	$36.52 - $41.46 $1,205 - $1,368	-33 Reduced 11.66%	250 $10,000
Q2 2020 Jul 24, 2020	BUY	$37.87 - $43.58 $9,467 - $10,895	250 Added 757.58%	283 $11,000
Q1 2019 May 01, 2019	BUY	$38.57 - $42.69 $1,272 - $1,408	33 New	33 $1,000
Q4 2017 Jan 29, 2018	SELL	$35.34 - $41.9 $881,733 - $1.05 Million	-24,950 Closed	0 $0
Q3 2017 Nov 03, 2017	SELL	$39.44 - $41.55 $37,468 - $39,472	-950 Reduced 3.67%	24,950 $1.01 Million
Q2 2017 Aug 09, 2017	BUY	N/A	25,900	25,900 $1.12 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Sterling Investment Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Sterling Investment Advisors, Ltd. with notifications on news.